Clinical Portfolio

Sixty million pounds dedicated to diabetes breakthrough science

Our multi-year research portfolio funds leading UK university laboratories investigating closed-loop artificial pancreas systems, remission mechanisms, and vascular protection.

£60M+

active portfolio

42

university labs

18

clinical trials

Active Frontiers

Three primary research fronts

Rigorous peer-reviewed investigations targeting automated delivery, metabolic remission, and long-term organ protection.

Technology
Metabolism
Vascular

Automated Insulin Delivery

Remission Science

Vascular Protection

Evaluating next-generation closed-loop systems and predictive algorithm safety across diverse patient cohorts in NHS clinical settings.

Long-term follow-up studies examining weight management interventions and sustained beta-cell function recovery mechanisms.

Targeting early microvascular preservation and novel therapeutic pathways to prevent long-term diabetes-related complications.

— Clinical Practice

Documentary photograph of clinical researchers analyzing trial outcomes alongside patient advocates at a UK university facility.

Open-access trial reports and patient summaries

Download vetted reference documents, school healthcare plans, and investigator summaries for clinical practice.